The use of genetic reporters for Sox2 activation to track cancer stem cells, published recently in Frontiers Oncology by the team of StemTek, is presented in the science radio show “El Laboratorio de JAL” (RNE-5), conducted by Jose Antonio López Guerrero, Director of the Science Culture Chair at the CBMSO. The audio (spanish) can be heard here.
In this interview, Eva Caballero talks about the recent news from Silicon Valley about the estratosfera valuation of Stemcntrx, start up dedicated to drug development in cancer targeting cancer stem cells. Angel Garcia Martin talks about how cancer stem cells are indeed a new frontier for anti-cancer drug development and how noe there is a revamped interest in pharma industry for novel therapeutics that control the growth of these populations. This is precisely the mission of StemTek The...
StemTek Therapeutics activity is profiled in the February issue of EmpresaXXI, bi-weekly journal of the basque enterprise. A bio of Angel García Martín, one of StemTek founders, is shown on page 10.
In this article the link between lipid metabolisms and self renewal in cancer stem cells is described, for the first time, through chemical inhibition of Acetyl-CoA Carboxilase (ACACA), derived from our collaboration with Dr. Javier Menendez’s group at ICO-Girona.
Back to top